Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anteris Technologies GlobalASX:AVR +1.30%42 3-1 Month Momentum % is 75.70% as of Jul. 22, 2026. GuruFocus rates ASX:AVR with a GF Score™ of 42/100. The stock has 5 warning signs investors should review. Among 844 Medical Devices & Instruments companies, Anteris Technologies Global ranks better than 99.17% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-22), Anteris Technologies Global's 3-1 Month Momentum % is 75.70%.
The industry rank for Anteris Technologies Global's 3-1 Month Momentum % or its related term are showing as below:
ASX:AVR's 3-1 Month Momentum % is ranked better than 99.17% of 844
companies
in the Medical Devices & Instruments industry
Industry Median: -10.035
vs ASX:AVR: 75.70
Anteris Technologies Global (ASX:AVR) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Anteris Technologies Global 3-1 Month Momentum % Related Terms
ASX:AVR vs QDEL, INMD, CNMD: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Anteris Technologies Global's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anteris Technologies Global 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Anteris Technologies Global's 3-1 Month Momentum % falls into.
Anteris Technologies Global (ASX:AVR) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anteris Technologies Global (ASX:AVR) has a 3-1 Month Momentum % of 75.70% as of Jul. 22, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Anteris Technologies Global and its competitors. According to the industry distribution chart, Anteris Technologies Global ranks #7 out of 844 companies in the Medical Devices & Instruments industry, placing it in the top 0.8%.
Is Anteris Technologies Global's 3-1 Month Momentum % too high?
Anteris Technologies Global's current 3-1 Month Momentum % is 75.70%. Based on the distribution chart, Anteris Technologies Global ranks #7 out of 844 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Anteris Technologies Global has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Anteris Technologies Global's 3-1 Month Momentum % compare to QDEL and INMD?
According to the Medical Devices & Instruments industry distribution chart, Anteris Technologies Global ranks #7 out of 844 companies for 3-1 Month Momentum %. This places Anteris Technologies Global in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Anteris Technologies Global and its competitors. Anteris Technologies Global's current 3-1 Month Momentum % is 75.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anteris Technologies Global stock overvalued right now?
Anteris Technologies Global (ASX:AVR) has a current 3-1 Month Momentum % of 75.70%. The current 3-1 Month Momentum % is 75.70%. Anteris Technologies Global's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Anteris Technologies Global (ASX:AVR), the current 3-1 Month Momentum % is 75.70% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
42GF Score
Get the complete analysis for ASX:AVR
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AVR has been successfully added to your 
